Human
APIs

We contribute to improving healthcare by providing high-quality APIs

In the Human API division of Suanfarma, we have a dedicated commercial team that provides an attractive and tailored portfolio for each customer, supported by our Quality and Regulatory Affairs departments.


With over 400 molecules for human pharmacological use, we comprehensively address different illnesses and therapeutic areas of interest to the pharmaceutical industry. Our range includes antibiotics, antivirals, antifungals, respiratory, oncological, cardiovascular products, and more.

Our success is grounded in the continuous search for new development proposals and alternative sources for all pharmacological groups. This commitment positions us at the forefront of innovation, guided by robust metrics and in-depth market studies, ensuring we meet the evolving needs of our customers.


We ensure compliance with Good Manufacturing Practices and closely monitor current legislation regarding proper distribution standards, guidelines, and international regulations applicable to the pharmaceutical industry. Furthermore, we possess all necessary marketing authorizations for our raw materials across global markets.

Proprietary APIs

THERAPEUTIC INDICATION

API

CEP/DMF

STATUS

ANTIBIOTICLYMECYCLINECEPCOMMERCIAL
MINOCYCLINE HYDROCHLORIDECEP, DMFCOMMERCIAL
MUPIROCINUNDER DEVELOPMENT
OXYTETRACYCLINE CALCIUMDMFCOMMERCIAL
OXYTETRACYCLINE DIHYDRATECOMMERCIAL
TETRACYCLINE HYDROCHLORIDECEP, DMFCOMMERCIAL
ANTIDIABETICCANAGLIFLOZIN HEMIHYDRATEUNDER DEVELOPMENT
EMPAGLIFLOZINUNDER DEVELOPMENT
ANTINEOPLASTIC AGENTRIBOCICLIB SUCCINATEUNDER DEVELOPMENT
OVULATION STIMULANTCLOMIFENE CITRATECEPCOMMERCIAL
Ovulation stimulants.
Antibiotics.
Antibiotics.
ovulation stimulant
Ovulation stimulants.
Antibiotic
Antibiotics.
Antibiotic
Antibiotics.

Strategic APIs

CHLORHEXIDINE BASE

Antiinfectives; US DMF & CEP available

DEXTROMETHORPHAN

Respiratory System; DMF available

ENOXAPARIN

Antithrombotic agents; DMF available

FAMOTIDINE

Metabolism

PREGABALIN

Nervous system; CEP available

RIVAROXABAN

Antithrombotic agents; DMF available

THYROID POWDER

Thyroid hormones; US DMF available

TRIMEBUTINE MALEATE

Metabolism

Strategic APIs

THERAPEUTIC INDICATION

API

CEP/DMF

STATUS

AGENT FOR DERMATITISCRISABOROLEUNDER DEVELOPMENT
ANTIBIOTICAZITHROMYCINCEP, DMFCOMMERCIAL
CIPROFLOXACINCEP, DMFCOMMERCIAL
CLARITHROMYCINCEP, DMFCOMMERCIAL
DOXYCYCLINE HYCLATECOMMERCIAL
MOXIFLOXACIN HYDROCHLORIDECOMMERCIAL
ROXITHROMYCINCEP, DMFCOMMERCIAL
ANTI-DEMENTIAGALANTAMINE HYDROBROMIDECEP, DMFCOMMERCIAL
ANTIDEPRESSANTAGOMELATINECOMMERCIAL
CITALOPRAMCEP, DMFCOMMERCIAL
FLUVOXAMINE MALEATECOMMERCIAL
ANTIDIABETICSITAGLIPTIN PHOSPHATE MONOHYDRATEDMFCOMMERCIAL
ANTIEMETICAPREPITANTCEP, DMFCOMMERCIAL
ANTIEPILEPTICCARBAMAZEPINECEP, DMFCOMMERCIAL
ESLICARBAZEPINE ACETATECEP, DMFCOMMERCIAL
LAMOTRIGINECEP, DMFCOMMERCIAL
OXCARBAZEPINECEP, DMFCOMMERCIAL
ANTINEOPLASTIC AGENTANASTROZOLECEPCOMMERCIAL
CABOZANTINIBUNDER DEVELOPMENT
PACRITINIB CITRATEUNDER DEVELOPMENT
PONATINIBUNDER DEVELOPMENT
SELUMETINIBUNDER DEVELOPMENT
TRAMETINIBUNDER DEVELOPMENT
ANTI-PARATHYROID AGENTCINACALCETCOMMERCIAL
ANTIPSYCHOTICSARIPIPRAZOLECEP, DMFCOMMERCIAL
CARIPRAZINE HYDROCHLORIDECOMMERCIAL
OLANZAPINECEP, DMFCOMMERCIAL
QUETIAPINE FUMARATECEP, DMFCOMMERCIAL
RISPERIDONECEP, DMFCOMMERCIAL
ANTITHROMBOTIC AGENTRIVAROXABANDMFCOMMERCIAL
BETA BLOCKING AGENTBISOPROLOL FUMARATECEPCOMMERCIAL
ERECTILE DYSFUNCTIONTADALAFILCEP, DMFCOMMERCIAL
HORMONE ANTAGONISTRELUGOLIXUNDER DEVELOPMENT
INMUNOSUPPRESSANTPIRFENIDONECEP, DMFCOMMERCIAL
NERVOUS SYSTEMPATISIRANUNDER DEVELOPMENT
OPIOIDTRAMADOL HYDROCHLORIDECEP, DMFCOMMERCIAL
PSYCHOLEPTICSUVOREXANTUNDER DEVELOPMENT
RESPIRATORY SYSTEMELEXACAFTORUNDER DEVELOPMENT
URINARY FREQUENCY AND INCONTINENCEMIRABEGRONCOMMERCIAL
SOLIFENACIN SUCCINATECEP, DMFCOMMERCIAL

Top distribution APIs

ALPHA LIPOIC ACID

Alimentary tract and metabolism; DMF available

ALPHA LIPOIC ACID COATED

Alimentary tract and metabolism; DMF available

BEMPEDOIC ACID

Lipid modifying agents; DMF available

BOSENTAN

Antihypertensives; DMF available

CHLORTHALIDONE

Diuretics; CEP available

CITALOPRAM

Antidepressants; CEP available

COLISTIMETHATE SODIUM

Intestinal antiinfectives; CEP available

ESCITALOPRAM

Antidepressants; DMF available

ESOMEPRAZOLE

Proton pump inhibitors; DMF available

FEXOFENADINE

Antihistamines; CEP available

FLUCONAZOLE

Antifungals for topical use; CEP available

GABAPENTIN

Nervous system; DMF available

HEPARIN SODIUM CRUDE

Intermediate (Enoxaparin and Bemiparin); Intermediate

IMATINIB MESYLATE

Antineoplastic agents; DMF available

LAMOTRIGINE

Antiepileptics; CEP available

LINAGLIPTIN

Blood glucose lowering drugs; CEP available

MEMANTINE

Nervous system; DMF available

OMEPRAZOLE

Proton pump inhibitors; CEP available

PANTOPRAZOLE

Proton pump inhibitors; CEP available

PIDOTIMOD

Immunostimulants; DMF available

QUETIAPINE FUMARATE

Antipsychotics; CEP available

TEMOZOLAMIDE

Antineoplastic agents; DMF available

TRAMADOL

Opioids ; CEP available

URSODEOXYCHOLIC ACID

Gallstones. Bile therapy; US DMF available

Research and development

API

USE

EMPAGLIFLOZINAntidiabetic
IBRUTINIBOncology
IMLIFIDASEAvoid rejection in kidney transplantation
LEMBOREXANTPsycholeptics
LUMATEPERONEAntipsychotic
PALBOCICLIBOncology
SAFINAMIDEParkinson
TIVOZANIBOncology
VIBEGRONUrinary Antiespasmodics
VOCLOSPORINLupus Nephritis

Items covered by valid patents are not offered or supplied for commercial use. Products under patent are available for R&D use only

Certifications

ISO 9001:2015

Certificate BPD-API

I+D
Our extensive
experience
supports us

APIs

Other products developed and manufactured under exclusive character

Contact us and we will provide you with details of our extensive product portfolio.

If you do not find the product you are looking for or are interested in developing a new one, please contact us.

I+D

APIs

Our extensive
experience
supports us

Other products developed and manufactured under exclusivity

If you cannot find the product you are looking for or are
interested in developing a new one, please contact us.